TOP NEWS: AstraZeneca wins three approvals in EU for cancer drugs
(Alliance News) - AstraZeneca PLC on Wednesday said its Imfinzi and Imjudo were approved in the European Union for the treatment of advanced liver and lung cancers. Its Calquence was also approved to treat chronic lymphocytic leukaemia. Read More